Where does Renovia Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Renovia Inc. ranks #21,684 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Renovia Inc. hold?

Renovia Inc. holds 13 US utility patents granted between 2016 and 2022, spanning 5 technology areas.

What is Renovia Inc.'s Innovation Score?

Renovia Inc. has an Innovation Score of 24.0 out of 100 (13th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Renovia Inc. focus on?

Renovia Inc.'s top technology area is C07C (Acyclic OR Carbocyclic Compounds) with 1 patents, ranking #1,980 of 2,691 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Renovia Inc.'s patent grant rate increasing or decreasing?

Renovia Inc.'s recent grant velocity is +1100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Renovia Inc.'s patents?

Renovia Inc.'s patents average 7.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Renovia Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Renovia Inc.

USPTO PatentsView assignee record - 13 granted patents across 5 technology areas, recorded in grant years 2016–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07C (Acyclic OR Carbocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Renovia ranks #21,684 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 5 technology areas.

#21,684
of 49,997 US assignees by volume: 13th percentile
by Innovation Score (24.0/100): 7.9
avg claims per patent: +1100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21684 · US Corporation #21,684 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #21,684/49,997
PHOTO-FINISH RegenLab USA
CPC-NARROW C07C · 5 areas
INNOV-THIN 24.0/100
CLAIMS-SPARSE 7.9 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +1100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: RegenLab USA LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Renovia’s 24.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (38%) Velocity 2.2 pts (9%) Breadth 7.9 pts (33%) Claim depth 4.8 pts (20%)

Qualcomm Incorporated · highest

85
Renovia · this assignee

24
3D Lighting… · lowest

7

What this shows Renovia's Innovation Score is 24.0/100 (13th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Renovia?

Each dot is one of Renovia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Renovia’s own 7.9 claims/patent is at or below the 19.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Renovia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Renovia's grants concentrate

Renovia Inc. is a focused PatentsView assignee: 5 CPC subclasses with 7.7% of grants classified under C07C (Acyclic OR Carbocyclic Compounds). Peak complete grant year is 2020 (8 grants) versus a trough of 1 in 2016. By volume, Renovia sits between RegenLab USA LLC and Richards Mfg. Co..

Renovia's three-year grant acceleration

Renovia Inc. shows 3 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Regenlab USA

13
Relamp

13
Relay Therapeutics

13
Relypsa

13
Respiratory Motion

13
Retailnext

13
Rhode Island Boar…

13
Richards Mfg

13
Renovia ◀

13

What this shows Renovia holds 13 patents at rank #21,696, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Renovia

By rank, the assignees closest to #21,696 in granted patent volume.

Leaders in C07C (Acyclic OR Carbocyclic Compounds)

Other assignees with the most granted patents in Renovia's primary technology class.

Renovia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

24 13th percentile higher than 13% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Renovia Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	7.7%
2020	8	61.5%
2021	1	7.7%
2022	3	23.1%

Which technologies does Renovia Inc. patent most?

C07C - Acyclic OR Carbocyclic Compounds 1

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

A61B - DIAGNOSIS; SURGERY; Identification 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

A63B - Apparatus FOR Physical Training, Gymnastics, Swimming, Climbing, OR FENCING; Ball GAMES; Training Equipment 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Renovia Inc.'s patent record in context - here's where to go next.

Renovia Inc.'s lead technology class is C07C (Acyclic OR Carbocyclic Compounds), 7.7% of its portfolio - see every assignee active in that class. Explore C07C
Ranked #21,684 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Renovia Inc. against RegenLab USA LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 24.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.